TDG vs WHWK · P/E 41, rev $8.83B vs $202.8M cap
Transdigm Group Incorporated (TDG) versus Whitehawk Therapeutics, Inc. (WHWK) — a side-by-side from cached financials, not a winner call.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
Whitehawk Therapeutics, Inc. (WHWK) is a biotechnology company listed on NASDAQ.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Latest reported WHWK revenue for 2026-06-30 was $0. Net income was -$38.8M. WHWK currently screens at market cap $202.8M.
TDG currently screens at market cap $73.65B and trailing P/E 41.1. WHWK currently screens at market cap $202.8M.
Not investment advice. Open the TDG and WHWK stock pages for the full models.
Not investment advice.